Skip to Main Content

Paper Details

A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial.
Oncotarget
2
2016
Author NameAffiliation
Melanie SpearsOntario Institute for Cancer Research
Melanie SpearsUniversity of Toronto
Nicola LyttleOntario Institute for Cancer Research
Alister D'CostaOntario Institute for Cancer Research
Alister D'CostaOntario Institute for Cancer Research
Cindy Q YaoOntario Institute for Cancer Research
Cindy Q YaoOntario Institute for Cancer Research
Paul C BoutrosOntario Institute for Cancer Research
Paul C BoutrosUniversity of Toronto
Paul C BoutrosUniversity of Toronto
Mark N LevineOntario Clinical Oncology Group, McMaster University
Lois ShepherdNCIC Clinical Trials Group (NCIC CTG) and Queen's University
John M S BartlettOntario Institute for Cancer Research
John M S BartlettUniversity of Toronto
John M S BartlettUniversity of Edinburgh
  • 1 - 15

Datasets

Release 1.2